U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
Nadravaleucel
USAN  
Official Name English
GDA-201
Preferred Name English
allogeneic natural killer (NK) cells isolated from peripheral blood leukapheresis of individual donors. The cells are co-cultured in media containing interleukin 15 (IL-15) and nicotinamide (NAM, niacinamide) with expansion enhanced by the presence of fe
Common Name English
NADRAVALEUCEL [USAN]
Common Name English
Code System Code Type Description
NCI_THESAURUS
C187130
Created by admin on Wed Apr 02 17:52:03 GMT 2025 , Edited by admin on Wed Apr 02 17:52:03 GMT 2025
PRIMARY
USAN
LM-191
Created by admin on Wed Apr 02 17:52:03 GMT 2025 , Edited by admin on Wed Apr 02 17:52:03 GMT 2025
PRIMARY
FDA UNII
S2RRP2SH5H
Created by admin on Wed Apr 02 17:52:03 GMT 2025 , Edited by admin on Wed Apr 02 17:52:03 GMT 2025
PRIMARY
SMS_ID
300000053867
Created by admin on Wed Apr 02 17:52:03 GMT 2025 , Edited by admin on Wed Apr 02 17:52:03 GMT 2025
PRIMARY
INN
12339
Created by admin on Wed Apr 02 17:52:03 GMT 2025 , Edited by admin on Wed Apr 02 17:52:03 GMT 2025
PRIMARY
ACTIVE MOIETY
Nadravaleucel
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966